Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

1.67
Delayed Data
As of 3:59pm ET
 +0.02 / +1.21%
Today’s Change
0.82
Today|||52-Week Range
3.75
-24.77%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close1.65
Today’s open1.66
Day’s range1.59 - 1.74
Volume1,253,759
Average volume (3 months)888,329
Market cap$223.3M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-50.98%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...+0.18+2.66%
CDXSCodexis Inc+0.09+2.08%
PRTOProteon Therapeutics...-0.08-0.89%
BSTCBiospecifics Technol...+0.75+1.63%
Data as of 4:00pm ET, 09/28/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts

Search for Jobs